Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Just a thought

<< Previous

Bullboard Posts

Next >>

Post by silverTon Dec 03, 2021 1:47pm

557 Views

Post# 34195838

Just a thought

What if we made a patient moderately anemic ....would that not cause the cancer cells to be starved for iron/oxygen , therefore would this not create more and faster Rutherrin absorption .

Way over my head.....but thinking

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec